Latest Articles
March 5, 2024
Greater than the Sum of its Parts: Gene-Disease Validity and Breast Cancer
Jennifer Herrera-Mullar discusses the correlation between breast-cancer associated genes and gene-disease validity
Genetic Testing
Hereditary Cancer
Variant of Unknown Significance
VUS
February 29, 2024
10 Ways Genetic Laboratories Can Support the Rare Disease Community
A top-ten list of ways laboratories can contribute to progress in identifying and treating rare disease for the more than 300 million people suffering from…
Advocacy Group
Novel Genes
Patient Advocate
VUS
Whole Exome Sequencing
February 26, 2024
From Awareness to Action: Supporting Rare Disease Today and Everyday
For Rare Disease Day, a list of patient advocacy groups dedicated to raising awareness about rare diseases and the millions of individuals around the world…
Advocacy Group
Novel Genes
Patient Advocate
VUS
Whole Exome Sequencing
February 23, 2024
Variant Interpretation in Real Time: Sometimes it Takes a Village
Genetic counselors explain how a CDH1 variant was classified as likely pathogenic from VUS status.
Breast Cancer
Genetic Testing
RNA
Variant of Unknown Significance
VUS
February 21, 2024
A GC’s Perspective on Lab Expertise: Getting Answers After Years of Uncertainty
Genetic counselor Kaitilin Stokes discusses hereditary cancer testing and resolving VUS in CDKN2! and APC genex.
Genetic Counselors
Genetic Testing
Hereditary Cancer
VUS
February 12, 2024
Meet Raymonde Saintil: Ambry Clinical Lab Manager
Ambry highlights clinical lab manager Raymonde Saintil for International Day of Women and Girls in Science.
Clinical Research
Women in STEM
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)